［1］Dohi T, Burkly LC. The TWEAK/Fn14 pathway as an aggravating and perpetuating factor in inflammatory diseases: focus on inflammatory bowel diseases\[J\]. J Leukoc Biol, 2012, 92(2): 265-279.［2］Kim SY, Kim JD, Sol IS, et al. Sputum TWEAK expression correlates with severity and degree of control in noneosinophilic childhood asthma\[J\]. Pediatr Allergy Immunol, 2018, 29 (1): 42-49.［3］李俊红,罗雅玲,赖文岩,等. 地塞米松对哮喘小鼠肺组织中TWEAK及其受体 Fn14 表达的调节作用\[J\]. 细胞与分子免疫学杂志, 2012, 28(11):1138-1141.［4］中华医学会儿科学分会呼吸学组,《中华儿科杂志》编辑委员会. 儿童支气管哮喘诊断与防治指南\[J\].中华儿科杂志, 2008, 46(10):745-753.［5］Burkly LC, Michaelson JS, Zheng TS. TWEAK/Fn14 pathway: an immunological switch for shaping tissue responses\[J\]. Immunol Rev, 2011, 244(1):99-114.［6］Fasolino M, Vahedi G. GR extinguishes inflamed chromatin, and NFκB evacuates\[J\]. Immunity, 2017, 47(2):214-216.［7］吕进泉,周弘,吕剑平,等.哮喘患儿血浆血栓素B2、6酮前列腺素F1α和血小板活化因子水平变化及意义\[J\].实用儿科临床杂志,2003, 18(6):445-446.［8］Liu YP, Yuan CM, Zhang SG, et al. TWEAK/Fn14 signaling: a promising target in intervertebral disc degeneration\[J\]. Histol Histopathol, 2016, 31(9):943-948.
2019, Vol. 29 
